{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:47:49Z","timestamp":1776984469018,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.euros.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T15:04:07Z","timestamp":1613574247000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Partial Versus Complete Bacillus Calmette-Gu\u00e9rin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non\u2013muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?"],"prefix":"10.1016","volume":"26","author":[{"given":"Michael E.","family":"Rezaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Aziz Ould","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiamaka L.","family":"Okorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Seigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine E.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian R.","family":"Schroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2021.01.009_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guerin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.08.027","article-title":"Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer","volume":"36","author":"Rieken","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euros.2021.01.009_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","article-title":"History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story","volume":"179","author":"Herr","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00345-018-2375-7","article-title":"Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer","volume":"37","author":"Thiel","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71:","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0040","first-page":"1","article-title":"Alternative therapies to bacillus Calmette-Gu\u00e9rin shortage for nonmuscle invasive bladder cancer in Brazil and other underdeveloped countries: management considerations","volume":"5","author":"Wroclawski","year":"2019","journal-title":"J Global Oncol"},{"key":"10.1016\/j.euros.2021.01.009_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/BLC-179018","article-title":"The BCG shortage","volume":"3","author":"Messing","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euros.2021.01.009_bib0050","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2020.04.066","volume":"78","author":"Grimm","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3442","article-title":"Extent of risk-aligned surveillance for cancer recurrence among patients with early-stage bladder cancer","volume":"1","author":"Schroeck","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euros.2021.01.009_bib0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.urology.2017.07.056","article-title":"Development of a natural language processing engine to generate bladder cancer pathology data for health services research","volume":"110","author":"Schroeck","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euros.2021.01.009_bib0065","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2021.01.009_bib0070","author":"Center of Excellence for Suicide Prevention"},{"key":"10.1016\/j.euros.2021.01.009_bib0075","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.euros.2021.01.009_bib0080","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/1475-6773.12454","article-title":"Risk adjustment tools for learning health systems: a comparison of DxCG and CMS-HCC V21","volume":"51","author":"Wagner","year":"2016","journal-title":"Health Serv Res"},{"key":"10.1016\/j.euros.2021.01.009_bib0085","author":"Wagner"},{"key":"10.1016\/j.euros.2021.01.009_bib0090","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2021.01.009_bib0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000020170","article-title":"What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?","volume":"37","author":"Zlotta","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.01.009_bib0100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3332\/ecancer.2019.905","article-title":"The use of intravesical BCG in urothelial carcinoma of the bladder","volume":"13","author":"Alhunaidi","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.euros.2021.01.009_bib0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euros.2021.01.009_bib0110","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.euros.2021.01.009_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1464-410X.2009.09076.x","article-title":"The effect of age and gender on bladder cancer: a critical review of the literature","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2021.01.009_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.urology.2018.07.055","article-title":"Utilization of bacillus Calmette-Guerin for nonmuscle invasive bladder cancer in an era of bacillus Calmette-Guerin supply shortages","volume":"124","author":"Khanna","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euros.2021.01.009_bib0125","first-page":"276","article-title":"The management of newly-diagnosed non-muscle invasive bladder cancer in Veterans Integrated Services Network 02 of the Veterans Health Administration","volume":"185","author":"Caputo","year":"2020","journal-title":"Mil Med"},{"key":"10.1016\/j.euros.2021.01.009_bib0130","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/cncr.26402","article-title":"Quality of care in patients with bladder cancer: a case report?","volume":"118","author":"Chamie","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2021.01.009_bib0135","author":"American Urological Association"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168321000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168321000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:05:44Z","timestamp":1762977944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168321000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"alternative-id":["S2666168321000161"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2021.01.009","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial Versus Complete Bacillus Calmette-Gu\u00e9rin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non\u2013muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}